Dissecting graft-versus-leukemia from graft-versus-host-disease using novel strategies
about
Novel immunotherapeutic approaches for the treatment of acute leukemia (myeloid and lymphoblastic)The role of pattern-recognition receptors in graft-versus-host disease and graft-versus-leukemia after allogeneic stem cell transplantationNovel therapeutic options in Acute Myeloid LeukemiaIn silico Derivation of HLA-Specific Alloreactivity Potential from Whole Exome Sequencing of Stem-Cell Transplant Donors and Recipients: Understanding the Quantitative Immunobiology of Allogeneic TransplantationHematopoietic stem-cell transplantation for advanced systemic mastocytosis.Acute myeloid leukemia: 2014 update on risk-stratification and management.Selective NFAT targeting in T cells ameliorates GvHD while maintaining antitumor activity.Allogeneic T Cells That Express an Anti-CD19 Chimeric Antigen Receptor Induce Remissions of B-Cell Malignancies That Progress After Allogeneic Hematopoietic Stem-Cell Transplantation Without Causing Graft-Versus-Host DiseaseLong-Term Stable Mixed Chimerism after Hematopoietic Stem Cell Transplantation in Patients with Non-Malignant Disease, Shall We Be Tolerant?ST2 blockade reduces sST2-producing T cells while maintaining protective mST2-expressing T cells during graft-versus-host disease.Proteomics analysis reveals a Th17-prone cell population in presymptomatic graft-versus-host disease.Donor-derived CD19-targeted T cells cause regression of malignancy persisting after allogeneic hematopoietic stem cell transplantation.Risk assessment before allogeneic hematopoietic cell transplantation for older adults with acute myeloid leukemia.Anti-thymocyte globulin as graft-versus-host disease prevention in the setting of allogeneic peripheral blood stem cell transplantation: a review from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.HIF-1α inhibitor echinomycin reduces acute graft-versus-host disease and preserves graft-versus-leukemia effectThinking out of the box--new approaches to controlling GVHD.Immunology of hematopoietic stem cell transplant.The potential of cytotherapeutics in hematologic reconstitution and in the treatment and prophylaxis of graft-versus-host disease. Chapter I: current practice and remaining unmet medical needs.Immunomodulatory Drugs: Immune Checkpoint Agents in Acute Leukemia.Neuromuscular complications of hematopoietic stem cell transplantation.New strategies of DLI in the management of relapse of hematological malignancies after allogeneic hematopoietic SCT.Advances in umbilical cord blood cell therapy: the present and the future.Recombinant IL-7/HGFβ hybrid cytokine separates acute graft-versus-host-disease from graft-versus-tumour activity by altering donor T cell trafficking.Flow cytometric analysis of the graft-versus-Leukemia-effect after hematopoietic stem cell transplantation in mice.Impact of graft-versus-host disease on outcomes after unrelated cord blood transplantation.IL-10-Engineered Human CD4(+) Tr1 Cells Eliminate Myeloid Leukemia in an HLA Class I-Dependent Mechanism.Emerging therapies for acute myeloid leukemia: translating biology into the clinic.HIV eradication--from Berlin to Boston.Specific Adoptive Cellular Immunotherapy in Allogeneic Stem Cell Transplantation.Specifically differentiated T cell subset promotes tumor immunity over fatal immunity.
P2860
Q26770391-706C359F-02FE-4DE3-931C-ED11DF90A694Q26824436-041B6E74-BBBA-49D3-9155-D23468B1D08BQ28069889-B3F2C655-FEBB-4B63-9390-F5D8C51F6F42Q34462528-31B2B646-1FFC-44A8-96E3-ABF2CE676724Q34664111-D112ED74-CF9C-4D68-803F-43DDCD5B4411Q34665691-78A5FC76-9095-4DE8-ABFA-F3FDEA417B4AQ35037993-F7D87D53-BCB6-414D-9224-0C0715539D7DQ35904666-4E747A11-E4ED-4E0A-B3DD-D053B2BE0541Q36010605-8851B5F8-7DBC-47F6-8165-0D14F851FEADQ36424657-C7A2CCDC-992B-40AC-8704-3B9D88C2A6D6Q36904560-67200A9A-D4AB-4102-9E34-259986A1C9ACQ37390239-8F864EE2-3548-433F-8E2F-1593E7502BE2Q37419348-7D8E1F61-F5CC-4BA4-BEBA-8D6572DF4155Q37618811-FA3A5EFC-42A4-449B-ADBC-A22D5FBBE7E2Q37635354-C559D915-C90A-41F9-9A25-4B9F6BC5F468Q38175862-3F19F1ED-389A-476D-BB80-D812917A435DQ38258161-C0C0CCDD-AF9E-4DD9-AFA8-C79D7F4FE605Q38453666-514F71F3-2D81-4F6B-9AA0-C070D2A421BDQ38485334-07D026C6-8768-4689-AEC9-4ACB35F65F2BQ38516316-BC00E289-5969-4AD8-8197-031F14266BA4Q38643400-132E7AC0-BE98-46BC-B828-7C632ECB152EQ38734758-36B8786A-7DA4-42B7-89A5-5BABA1BA9D40Q38736579-51240726-65FE-4612-8C1A-4EAA4E822DE3Q38905932-10027080-07D6-4C70-9E6A-6A2ACD760A51Q39283573-86E16141-DAC1-4E84-A004-F9CDDEAFA67FQ40093839-E31FBCBC-6417-4E16-A22F-70B9BF6A378BQ41984963-C2643F89-2AB6-4195-8206-E4D6D07BFBABQ46066247-DA8D3BCF-CB71-4EE9-AFD7-04122A5BCF33Q47566513-8A028A45-8952-449C-9B82-AFE2DC35FD02Q47643463-EE72D085-6CBB-4439-B47A-DA46D0A93303
P2860
Dissecting graft-versus-leukemia from graft-versus-host-disease using novel strategies
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Dissecting graft-versus-leukemia from graft-versus-host-disease using novel strategies
@ast
Dissecting graft-versus-leukemia from graft-versus-host-disease using novel strategies
@en
type
label
Dissecting graft-versus-leukemia from graft-versus-host-disease using novel strategies
@ast
Dissecting graft-versus-leukemia from graft-versus-host-disease using novel strategies
@en
prefLabel
Dissecting graft-versus-leukemia from graft-versus-host-disease using novel strategies
@ast
Dissecting graft-versus-leukemia from graft-versus-host-disease using novel strategies
@en
P2860
P356
P1433
P1476
Dissecting graft-versus-leukemia from graft-versus-host-disease using novel strategies
@en
P2093
E H Warren
P2860
P304
P356
10.1111/TAN.12090
P577
2013-04-01T00:00:00Z